Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Marimed (MRMD) over the last 10 years, with Q3 2025 value amounting to $7000.0.

  • Marimed's Income from Non-Controlling Interests fell 5625.0% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41000.0, marking a year-over-year decrease of 3593.75%. This contributed to the annual value of $37000.0 for FY2024, which is 5416.67% up from last year.
  • As of Q3 2025, Marimed's Income from Non-Controlling Interests stood at $7000.0, which was down 5625.0% from -$1000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Income from Non-Controlling Interests ranged from a high of $110000.0 in Q4 2021 and a low of -$19000.0 during Q1 2023
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was $16000.0 (2022), whereas its average is $33894.7.
  • Data for Marimed's Income from Non-Controlling Interests shows a peak YoY increase of 65000.0% (in 2023) and a maximum YoY decrease of 16250.0% (in 2023) over the last 5 years.
  • Over the past 5 years, Marimed's Income from Non-Controlling Interests (Quarter) stood at $110000.0 in 2021, then tumbled by 96.36% to $4000.0 in 2022, then skyrocketed by 650.0% to $30000.0 in 2023, then crashed by 90.0% to $3000.0 in 2024, then surged by 133.33% to $7000.0 in 2025.
  • Its last three reported values are $7000.0 in Q3 2025, -$1000.0 for Q2 2025, and $32000.0 during Q1 2025.